Qi Yueying, Fan Lirong, Ran Decong, Xu Jieda, Wang Yuansong, Wu Jin, Zhang Zhongyong
Department of Gastroenterology and Hepatology, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, 31 West Huanghe Road, Cangzhou, Hebei, China.
Department of Endocrinology, The Traditional Chinese Medicine Hospital of Botou, West Shengli Road, Botou, Hebei, China.
J Oncol. 2021 Oct 13;2021:7764817. doi: 10.1155/2021/7764817. eCollection 2021.
Type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver disease (NAFLD) is a pathological metabolic disease characterized by high ketone lipid based on abnormal lipid metabolism. Compared with patients with single T2DM or NAFLD, T2DM complicated with NAFLD has more complicated pathogenic factors and pathological processes. Hepatocellular carcinoma (HCC), the leading malignancy arising from cirrhosis, is the second most lethal cancer globally. The purpose of this study was to clarify the main risk factors of T2DM with NAFLD and HCC. There are many challenges in the diagnosis and treatment of T2DM patients with NAFLD and HCC. The current gold standard is to adjust treatment strategy, optimize metabolic control, and improve liver phenotype. It is necessary to identify further the risk factors driving the progression of T2DM with NAFLD and HCC and evaluate new therapeutic targets, in addition to exploring the syndromic forms of T2DM combined with NAFLD and providing a theoretical basis for early prevention, diagnosis, and treatment of the disease using traditional Chinese medicine (TCM).
2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)是一种基于脂质代谢异常以高酮脂为特征的病理性代谢疾病。与单纯T2DM或NAFLD患者相比,T2DM合并NAFLD具有更复杂的致病因素和病理过程。肝细胞癌(HCC)是肝硬化引发的主要恶性肿瘤,是全球第二大致命癌症。本研究的目的是阐明T2DM合并NAFLD及HCC的主要危险因素。T2DM合并NAFLD及HCC患者的诊断和治疗存在诸多挑战。当前的金标准是调整治疗策略、优化代谢控制并改善肝脏表型。除了探索T2DM合并NAFLD的综合征形式,并为使用传统中医(TCM)对该疾病进行早期预防、诊断和治疗提供理论依据外,进一步识别驱动T2DM合并NAFLD及HCC进展的危险因素并评估新的治疗靶点也很有必要。